These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1359697)

  • 21. Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice.
    Rokita H; Shirahama T; Cohen AS; Sipe JD
    Br J Exp Pathol; 1989 Jun; 70(3):327-35. PubMed ID: 2765389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic mechanisms of amyloid A amyloidosis.
    Simons JP; Al-Shawi R; Ellmerich S; Speck I; Aslam S; Hutchinson WL; Mangione PP; Disterer P; Gilbertson JA; Hunt T; Millar DJ; Minogue S; Bodin K; Pepys MB; Hawkins PN
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16115-20. PubMed ID: 23959890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
    Kisilevsky R; Tan R; Subrahmanyan L; Snow A
    Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological study of experimental murine AA amyloidosis.
    Kuroiwa M; Aoki K; Izumiyama N
    J Electron Microsc (Tokyo); 2003; 52(4):407-13. PubMed ID: 14599103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis.
    Phipps-Yonas H; Pinard G; Ali-Khan Z
    Scand J Immunol; 2004 Feb; 59(2):168-76. PubMed ID: 14871293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitin profile in inflammatory leukocytes and binding of ubiquitin to murine AA amyloid: immunocytochemical and immunogold electron microscopic studies.
    Alizadeh-Khiavi K; Li W; Chronopoulos S; Ali-Khan Z
    J Pathol; 1994 Feb; 172(2):209-17. PubMed ID: 8169751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.
    Kennel SJ; Macy S; Wooliver C; Huang Y; Richey T; Heidel E; Wall JS
    Amyloid; 2014 Mar; 21(1):45-53. PubMed ID: 24446872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
    Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
    Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
    Kawahara E; Shiroo M; Nakanishi I; Migita S
    Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate inhibits reactive amyloidosis in mice.
    Murai T; Yamada T; Miida T; Arai K; Endo N; Hanyu T
    Arthritis Rheum; 2002 Jun; 46(6):1683-8. PubMed ID: 12115201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice.
    Ham D; Caouras V; Radzioch D; Gervais F
    Scand J Immunol; 1997 Apr; 45(4):354-60. PubMed ID: 9105421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F; Hébert L; Skamene E
    J Leukoc Biol; 1988 Apr; 43(4):311-6. PubMed ID: 3162509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid deposition in granuloma of tuberculosis patients: A single-center pilot study.
    Ghosh S; Kala C; Garg A; Thakur AK
    Tuberculosis (Edinb); 2022 Sep; 136():102249. PubMed ID: 35998384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Kupffer cell function precedes development of secondary amyloidosis.
    Fuks A; Zucker-Franklin D
    J Exp Med; 1985 May; 161(5):1013-28. PubMed ID: 3989470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.